Page 100 - 2026 SMOG
P. 100

ALBUTEROL (PROVENTIL/VENTOLIN)
                              Class/Mechanism of Action
         •  Beta  Agonist (Bronchodilator)
              2
           Synthetic sympathomimetic that relaxes bronchial smooth muscle, causing bronchodilation, with little
           cardiac impact.
              ˚  Onset of action: 2–15min
                                    Indications
         •  Labeled Indications
              ˚  Treatment or prevention of bronchospasm in patients with reversible obstructive airway disease;
             prevention of exercise-induced bronchospasm
              ˚  Asthma
              ˚  Reactive airway/bronchospasm
              ˚
             COPD
         •  Off-Label Indications
              ˚  May also be used in crush syndrome (hyperkalemia)
                                  Contraindications
         •  Hypersensitivity to albuterol or any component of the formulation
         •  Hypersensitivity to milk protein (dry powder inhalers)
                            Adverse Reactions/Precautions
         •  May cause CNS effects such as headache, dizziness, flushing, diaphoresis, tremors, weakness
         •  May cause mild tachycardia, chest pain, cardiac arrhythmias, QTc interval changes, and more severe
           cases of cardiac ischemia, heart failure, and cardiomyopathy
         •  Dyspnea, paradoxical bronchospasm due to airway hyperresponsiveness
         •  Pregnancy: Category C
         •  Lactation: Yes
                                Dose/Administration
                                                     PEDIATRIC
                      ADULT
                                              (Always reference Broselow Tape)
         Bronchospasm; Anaphylaxis (adjunct to   By Metered Dose Inhaler
         epinephrine)                    (MDI; 90mcg/actuation)
         •  Metered-dose inhaler (90mcg/actuation)  •  4–8 inhalations q20min prn for 3 doses, then
              ˚  2–3 inhalations prn       q1–4hr or as clinically indicated
         •  Nebulization solution        By Nebulizer (Intermittent)
              ˚  2.5–5mg; repeat prn     •  Children <20kg
         Severe Exacerbation of Asthma        ˚  2.5mg q20min prn
         •  Metered-dose inhaler         •  Children >20kg
              ˚  2–4 inhalations q20min prn for 3 doses,     ˚  5mg q20min prn
             then taper as tolerated
         •  Nebulization solution        By Nebulizer (Continuous)
                                         •  0.5mg/kg/hr and titrate prn, max 20mg/hr
              ˚  2.5–5mg q20min for 3 doses, then taper as
             tolerated
         Hyperkalemia
         •  Nebulization solution
              ˚  10mg over 10min



        92  •   MEDICATIONS
   95   96   97   98   99   100   101   102   103   104   105